NCT03092895 2026-01-29
A Study of SHR-1210 in Combination With Apatinib or Chemotherapy in Subjects With Advanced PLC or BTC
Jiangsu HengRui Medicine Co., Ltd.
Phase 2 Completed
Jiangsu HengRui Medicine Co., Ltd.
Shandong Public Health Clinical Center
BeiJing Yijiayi Medicine Techonoloy Co., Ltd.
BeiJing Yijiayi Medicine Techonoloy Co., Ltd.